ByteDance’s Anew Labs presents first AI-designed therapy as TikTok parent enters drug discovery race
TL;DRByteDance’s drug discovery unit Anew Labs presented its first AI-designed therapy at a major immunology conference in Boston, showing a generative-AI-designed small molecule targeting IL-17, a protein-protein interaction long considered...
